Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.

Soverini S, Mancini M, Bavaro L, Cavo M, Martinelli G.

Mol Cancer. 2018 Feb 19;17(1):49. doi: 10.1186/s12943-018-0780-6. Review.

2.

FuSpot: a web-based tool for visual evaluation of fusion candidates.

Killian JA, Topiwala TM, Pelletier AR, Frankhouser DE, Yan PS, Bundschuh R.

BMC Genomics. 2018 Feb 13;19(1):139. doi: 10.1186/s12864-018-4486-3.

3.

Transcriptional-Readthrough RNAs Reflect the Phenomenon of "A Gene Contains Gene(s)" or "Gene(s) within a Gene" in the Human Genome, and Thus Are Not Chimeric RNAs.

He Y, Yuan C, Chen L, Lei M, Zellmer L, Huang H, Liao DJ.

Genes (Basel). 2018 Jan 16;9(1). pii: E40. doi: 10.3390/genes9010040. Review.

4.

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia.

Sun Y, Zhao N, Wang H, Wu Q, Han Y, Liu Q, Wu M, Liu Y, Kong F, Wang H, Sun Y, Sun D, Jing L, Tang G, Hu Y, Xiao D, Luo H, Han Y, Peng Y.

J Cancer. 2017 Aug 23;8(14):2774-2784. doi: 10.7150/jca.18731. eCollection 2017.

5.

GFusion: an Effective Algorithm to Identify Fusion Genes from Cancer RNA-Seq Data.

Zhao J, Chen Q, Wu J, Han P, Song X.

Sci Rep. 2017 Jul 31;7(1):6880. doi: 10.1038/s41598-017-07070-6.

6.

Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases.

Greer SU, Nadauld LD, Lau BT, Chen J, Wood-Bouwens C, Ford JM, Kuo CJ, Ji HP.

Genome Med. 2017 Jun 19;9(1):57. doi: 10.1186/s13073-017-0447-8.

7.

It Is Imperative to Establish a Pellucid Definition of Chimeric RNA and to Clear Up a Lot of Confusion in the Relevant Research.

Yuan C, Han Y, Zellmer L, Yang W, Guan Z, Yu W, Huang H, Liao DJ.

Int J Mol Sci. 2017 Mar 28;18(4). pii: E714. doi: 10.3390/ijms18040714. Review.

8.

Genomics of chronic neutrophilic leukemia.

Maxson JE, Tyner JW.

Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27. Review.

9.

Molecular pathology of cancer: how to communicate with disease.

Birner P, Prager G, Streubel B.

ESMO Open. 2016 Nov 17;1(5):e000085. eCollection 2016. Review.

10.

Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.

Xie H, Peng C, Huang J, Li BE, Kim W, Smith EC, Fujiwara Y, Qi J, Cheloni G, Das PP, Nguyen M, Li S, Bradner JE, Orkin SH.

Cancer Discov. 2016 Nov;6(11):1237-1247. Epub 2016 Sep 14.

11.

Summary of the published Indian data on chronic myeloid leukemia.

Singhal MK, Sengar M, Nair R.

South Asian J Cancer. 2016 Jul-Sep;5(3):162-5. doi: 10.4103/2278-330X.187593. Review.

12.

Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases.

López-Andrade B, Sartori F, Gutiérrez A, García L, Cunill V, Durán MA, Sampol A, Bernués M, Iglesias J, Ramos R, Lladó J, Sánchez M, Amat JC, Martínez-Serra J.

Exp Hematol Oncol. 2016 Jul 29;5:21. doi: 10.1186/s40164-016-0049-y. eCollection 2015.

13.

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives.

Patel JN.

Pharmgenomics Pers Med. 2016 Jul 12;9:65-77. doi: 10.2147/PGPM.S62918. eCollection 2016. Review.

14.

Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target.

Toman O, Kabickova T, Vit O, Fiser R, Polakova KM, Zach J, Linhartova J, Vyoral D, Petrak J.

Oncol Rep. 2016 Sep;36(3):1258-68. doi: 10.3892/or.2016.4945. Epub 2016 Jul 18.

15.

The Genotoxic and Cytotoxic Effects of Bisphenol-A (BPA) in MCF-7 Cell Line and Amniocytes.

Aghajanpour-Mir SM, Zabihi E, Akhavan-Niaki H, Keyhani E, Bagherizadeh I, Biglari S, Behjati F.

Int J Mol Cell Med. 2016 Winter;5(1):19-29.

16.

Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.

Qin F, Song Z, Chang M, Song Y, Frierson H, Li H.

Cancer Lett. 2016 Sep 28;380(1):39-46. doi: 10.1016/j.canlet.2016.06.013. Epub 2016 Jun 17.

17.

Best Practices in Chronic Myeloid Leukemia Monitoring and Management.

Soverini S, De Benedittis C, Mancini M, Martinelli G.

Oncologist. 2016 May;21(5):626-33. doi: 10.1634/theoncologist.2015-0337. Epub 2016 Mar 31. Review.

18.

Current Role of Genetics in Hematologic Malignancies.

Prakash G, Kaur A, Malhotra P, Khadwal A, Sharma P, Suri V, Varma N, Varma S.

Indian J Hematol Blood Transfus. 2016 Mar;32(1):18-31. doi: 10.1007/s12288-015-0584-4. Epub 2015 Sep 16. Review.

19.

Nanopore sequencing detects structural variants in cancer.

Norris AL, Workman RE, Fan Y, Eshleman JR, Timp W.

Cancer Biol Ther. 2016;17(3):246-53. doi: 10.1080/15384047.2016.1139236. Epub 2016 Jan 19.

20.

SPR Detection and Discrimination of the Oligonucleotides Related to the Normal and the Hybrid bcr-abl Genes by Two Stringency Control Strategies.

Matsishin MJ, Ushenin IuV, Rachkov AE, Solatkin AP.

Nanoscale Res Lett. 2016 Dec;11(1):19. doi: 10.1186/s11671-016-1226-y. Epub 2016 Jan 13.

Supplemental Content

Support Center